135 related articles for article (PubMed ID: 35800421)
21. Head-to-head comparison of the hybrid tracer indocyanine green-99mTc-nanocolloid with 99mTc-Senti-Scint using sentinel node lymphoscintigraphy and single-photon emission computed tomography combined with computer tomography in melanoma.
Rietbergen DDD; Meershoek P; KleinJan GH; Donswijk M; Valdés Olmos RA; van Leeuwen FWB; Klop MWMC; van der Hage JA
Nucl Med Commun; 2020 Oct; 41(10):1010-1017. PubMed ID: 32925825
[TBL] [Abstract][Full Text] [Related]
22. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
Grimes J; Celler A; Birkenfeld B; Shcherbinin S; Listewnik MH; Piwowarska-Bilska H; Mikolajczak R; Zorga P
J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
[TBL] [Abstract][Full Text] [Related]
23. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
[TBL] [Abstract][Full Text] [Related]
25. (99m)Tc-HYNIC-TOC scintigraphy in evaluation of active Graves' ophthalmopathy (GO).
Sun H; Jiang XF; Wang S; Chen HY; Sun J; Li PY; Ning G; Zhao YJ
Endocrine; 2007 Jun; 31(3):305-10. PubMed ID: 17906380
[TBL] [Abstract][Full Text] [Related]
26. Glomus Tumor of the Neck Detected With 99mTc EDDA HYNIC-TOC.
Girotto N; Bogović-Crnčić T; Grbac-Ivanković S; Valković-Zujić P
Clin Nucl Med; 2017 Oct; 42(10):758-760. PubMed ID: 28806247
[TBL] [Abstract][Full Text] [Related]
27. (99m)Tc-Phytate Lymphoscintigraphy for Detection of Sentinel Node: Preliminary Results of the First Year's Clinical Experience in Isfahan, Iran.
Moslehi M; Shanei A; Hakimian SM; Mahmoudi G; Baradaran-Ghahfarokhi M
J Med Signals Sens; 2015; 5(1):69-74. PubMed ID: 25709943
[TBL] [Abstract][Full Text] [Related]
28. Improved kit formulation for preparation of (99m)Tc-HYNIC-TOC: results of preliminary clinical evaluation in imaging patients with neuroendocrine tumors.
Korde A; Mallia M; Shinto A; Sarma HD; Samuel G; Banerjee S
Cancer Biother Radiopharm; 2014 Nov; 29(9):387-94. PubMed ID: 25379612
[TBL] [Abstract][Full Text] [Related]
29. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
Guo H; Miao Y
J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
[TBL] [Abstract][Full Text] [Related]
30. Clinical indications to the use of (99m)Tc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors.
Parisella MG; Chianelli M; D'Alessandria C; Todino V; Mikolajczak R; Papini E; Dierckx RA; Scopinaro F; Signore A
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):90-8. PubMed ID: 21068709
[TBL] [Abstract][Full Text] [Related]
31. SPECT Imaging of SST2-Expressing Tumors with
Gaonkar RH; Wiesmann F; Del Pozzo L; McDougall L; Zanger S; Mikołajczak R; Mansi R; Fani M
Pharmaceuticals (Basel); 2021 Mar; 14(4):. PubMed ID: 33800582
[TBL] [Abstract][Full Text] [Related]
32. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
[TBL] [Abstract][Full Text] [Related]
33. Patient-specific dosimetry of
Hou X; Birkenfeld B; Piwowarska-Bilska H; Celler A
EJNMMI Phys; 2017 Oct; 4(1):24. PubMed ID: 29030760
[TBL] [Abstract][Full Text] [Related]
34. Image fusion analysis of 99m Tc-HYNIC-octreotide scintigraphy and CT/MRI in patients with thyroid-associated orbitopathy: the importance of the lacrimal gland.
Kainz H; Bale R; Donnemiller E; Gabriel M; Kovacs P; Decristoforo C; Moncayo R
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1155-9. PubMed ID: 12811420
[TBL] [Abstract][Full Text] [Related]
35.
Liepe K; Becker A
World J Nucl Med; 2018; 17(3):151-156. PubMed ID: 30034278
[TBL] [Abstract][Full Text] [Related]
36. Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.
Kopecky M; Semecky V; Trejtnar F; Laznicek M; Laznickova A; Nachtigal P; Decristoforo C; Mather SJ; Mäcke HR
Nucl Med Biol; 2004 Feb; 31(2):231-9. PubMed ID: 15013489
[TBL] [Abstract][Full Text] [Related]
37. Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy.
Kobayashi K; Ramirez PT; Kim EE; Levenback CF; Rohren EM; Frumovitz M; Mar MV; Gayed IW
Clin Nucl Med; 2009 Dec; 34(12):859-61. PubMed ID: 20139817
[TBL] [Abstract][Full Text] [Related]
38. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
[TBL] [Abstract][Full Text] [Related]
39. Positive lymphoscintigraphy (ILS) and negative computed tomography for metastatic penile cancer.
Bantis A; Sountoulides P; Kalaitzis C; Boussios N; Giannakopoulos S; Zissimopoulos A
Hell J Nucl Med; 2011; 14(3):309-10. PubMed ID: 22087456
[TBL] [Abstract][Full Text] [Related]
40. Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection: Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes.
Stoffels I; Dissemond J; Pöppel T; Schadendorf D; Klode J
JAMA Surg; 2015 Jul; 150(7):617-23. PubMed ID: 26017057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
